Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125043242 | 12504324 | 2 | F | 20130627 | 20160913 | 20160628 | 20160916 | PER | US-PFIZER INC-2016320011 | PFIZER | 45.00 | YR | M | Y | 0.00000 | 20160916 | LW | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125043242 | 12504324 | 1 | PS | DEPO-TESTOSTERONE | TESTOSTERONE CYPIONATE | 1 | UNK, ONCE EVERY TWO WEEKS | U | 85635 | SOLUTION FOR INJECTION | |||||||||
| 125043242 | 12504324 | 2 | SS | DEPO-TESTOSTERONE | TESTOSTERONE CYPIONATE | 1 | U | 85635 | SOLUTION FOR INJECTION | ||||||||||
| 125043242 | 12504324 | 3 | SS | ANDROGEL | TESTOSTERONE | 1 | UNK, PUMP 1.62%, 1X/DAY | D | 0 | GEL | QD | ||||||||
| 125043242 | 12504324 | 4 | SS | TESTOSTERONE CYPIONATE. | TESTOSTERONE CYPIONATE | 1 | UNK, ONCE EVERY TWO WEEKS | U | 0 | ||||||||||
| 125043242 | 12504324 | 5 | SS | FORTESTA | TESTOSTERONE | 1 | UNK, 1X/DAY | U | 0 | QD | |||||||||
| 125043242 | 12504324 | 6 | C | TRAMADOL HYDROCHLORIDE. | TRAMADOL HYDROCHLORIDE | 1 | 50 MG, UNK | 0 | 50 | MG | TABLET | ||||||||
| 125043242 | 12504324 | 7 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | 50 UG, UNK | 0 | 50 | UG | TABLET | ||||||||
| 125043242 | 12504324 | 8 | C | OXYCODONE HYDROCHLORIDE. | OXYCODONE HYDROCHLORIDE | 1 | 5 MG, UNK | 0 | 5 | MG | TABLET | ||||||||
| 125043242 | 12504324 | 9 | C | ZOLPIDEM TARTRATE. | ZOLPIDEM TARTRATE | 1 | 6.25 MG, UNK | 0 | 6.25 | MG | TABLET | ||||||||
| 125043242 | 12504324 | 10 | C | CYCLOBENZAPRINE HYDROCHLORIDE. | CYCLOBENZAPRINE HYDROCHLORIDE | 1 | 5 MG, UNK | 0 | 5 | MG | TABLET | ||||||||
| 125043242 | 12504324 | 11 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | 20 MG, UNK | 0 | 20 | MG | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125043242 | 12504324 | 1 | Hormone replacement therapy |
| 125043242 | 12504324 | 2 | Blood testosterone decreased |
| 125043242 | 12504324 | 3 | Hormone replacement therapy |
| 125043242 | 12504324 | 4 | Hormone replacement therapy |
| 125043242 | 12504324 | 5 | Hormone replacement therapy |
| 125043242 | 12504324 | 6 | Back pain |
| 125043242 | 12504324 | 7 | Hypothyroidism |
| 125043242 | 12504324 | 8 | Fibromyalgia |
| 125043242 | 12504324 | 9 | Insomnia |
| 125043242 | 12504324 | 10 | Back pain |
| 125043242 | 12504324 | 11 | Blood cholesterol increased |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125043242 | 12504324 | HO |
| 125043242 | 12504324 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125043242 | 12504324 | Myocardial infarction |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125043242 | 12504324 | 1 | 20120725 | 201306 | 0 | |
| 125043242 | 12504324 | 3 | 201203 | 201204 | 0 | |
| 125043242 | 12504324 | 4 | 201204 | 0 | ||
| 125043242 | 12504324 | 5 | 201205 | 0 | ||
| 125043242 | 12504324 | 6 | 201302 | 201402 | 0 | |
| 125043242 | 12504324 | 7 | 201204 | 201502 | 0 | |
| 125043242 | 12504324 | 8 | 201204 | 201309 | 0 | |
| 125043242 | 12504324 | 9 | 201210 | 201401 | 0 | |
| 125043242 | 12504324 | 10 | 201301 | 201310 | 0 | |
| 125043242 | 12504324 | 11 | 201306 | 201404 | 0 |